1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Angiogenesis, Pathologic in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 10 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banach, M; Cole, JA; Czaplewska, P; Czerwinski, A; Dobrucki, IT; Dobrucki, LW; Hedhli, J; Hood, L; Imoukhuede, P; Kalinowski, L; Mamer, SB; Płoska, A; Schuelke, M; Sowinski, P | 1 |
Barnhart, TE; Cai, W; Hong, H; Myklejord, DV; Nayak, TR; Theuer, CP; Valdovinos, HF; Zhang, Y | 1 |
Arbeit, JM; Chang, AJ; Lapi, SE; Lu, ZH; Sohn, R | 1 |
Cai, W; Chen, F; Ehlerding, EB; Goel, S; Graves, SA; Hong, H; Nickles, RJ; Orbay, H; Shi, S; Theuer, CP | 1 |
Backer, JM; Backer, M; Eder, M; Eisenhut, M; Haberkorn, U; Krivoshein, AV | 1 |
Chung, JK; Jeong, JM; Jeong, SY; Ju, CH; Kim, YJ; Lee, BC; Lee, DS; Lee, MC; Lee, YS | 1 |
Cheng, Z; Jiang, H; Liu, H; Liu, S; Xu, Y; Zhang, H | 1 |
Han, SW; Jeong, JM; Kang, KW; Kim, JH; Kim, TY; Lee, DS; Lee, HY; Lee, JS; Lee, YS | 1 |
Barnhart, TE; Bean, J; Cai, W; Engle, JW; Feng, L; Goel, S; Hong, H; Liu, Z; Nayak, TR; Theuer, CP; Yang, K; Yang, Y; Zhang, Y | 1 |
Choe, YS; Kang, CM; Kim, SM; Koo, HJ; Lee, KH; Ryu, EK; Yim, MS | 1 |
10 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Angiogenesis, Pathologic
Article | Year |
---|---|
Synthesis, Chemical Characterization and Multiscale Biological Evaluation of a Dimeric-cRGD Peptide for Targeted Imaging of α
Topics: Animals; Cell Line, Tumor; Copper Radioisotopes; Dimerization; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Human Umbilical Vein Endothelial Cells; Humans; Integrin alphaVbeta3; Kidney; Mice; Neovascularization, Pathologic; Oligopeptides; Peptides, Cyclic; Positron-Emission Tomography; Rats; Tissue Distribution | 2017 |
Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.
Topics: Animals; Antibodies, Monoclonal; Benzenesulfonates; Breast Neoplasms; Copper Radioisotopes; Endoglin; Female; Flow Cytometry; Fluorescence; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Luciferases; Luminescent Measurements; Lung Neoplasms; MCF-7 Cells; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Positron-Emission Tomography | 2013 |
Detection of rapalog-mediated therapeutic response in renal cancer xenografts using ⁶⁴Cu-bevacizumab immunoPET.
Topics: Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Everolimus; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Kidney Neoplasms; Mice; Neovascularization, Pathologic; Phosphorylation; Positron-Emission Tomography; Sirolimus; Treatment Outcome; Vascular Endothelial Growth Factor A | 2013 |
In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.
Topics: Ablation Techniques; Animals; Antineoplastic Agents; Copper; Drug Carriers; Endoglin; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Intracellular Signaling Peptides and Proteins; Mammary Neoplasms, Experimental; Mice; Nanostructures; Neovascularization, Pathologic; Polyethylene Glycols; Porosity; Positron-Emission Tomography; Silicon Dioxide; Theranostic Nanomedicine; Tissue Distribution | 2015 |
ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature.
Topics: Acetates; Animals; Cell Line, Tumor; Chelating Agents; Cysteine; Ethylenediamines; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Mice; Neovascularization, Pathologic; Polyethylene Glycols; Positron-Emission Tomography; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Vascular Endothelial Growth Factor A | 2010 |
Development of a ¹⁷⁷Lu-labeled RGD derivative for targeting angiogenesis.
Topics: Animal Structures; Animals; Chelating Agents; Chromatography, High Pressure Liquid; Colonic Neoplasms; Drug Delivery Systems; Drug Stability; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Kidney; Lutetium; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Neovascularization, Pathologic; Oligopeptides; Radioisotopes; Radiopharmaceuticals; Tissue Distribution | 2010 |
One-step radiosynthesis of ¹⁸F-AlF-NOTA-RGD₂ for tumor angiogenesis PET imaging.
Topics: Animals; Cell Line, Tumor; Drug Stability; Female; Glioblastoma; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Integrins; Mice; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Radiochemistry | 2011 |
Whole-body distribution and radiation dosimetry of (68)Ga-NOTA-RGD, a positron emission tomography agent for angiogenesis imaging.
Topics: Adult; Aged; Female; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Radiation Dosage; Radiometry; Radiopharmaceuticals; Tissue Distribution | 2012 |
In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Cell Line, Tumor; Copper Radioisotopes; Endoglin; Graphite; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Human Umbilical Vein Endothelial Cells; Humans; Immunoconjugates; Isotope Labeling; Mammary Neoplasms, Experimental; Mice; Molecular Imaging; Nanoconjugates; Neovascularization, Pathologic; Oxides; Positron-Emission Tomography; Receptors, Cell Surface | 2012 |
In vivo characterization of 68Ga-NOTA-VEGF 121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models.
Topics: Animals; Calibration; Cell Line, Tumor; Chelating Agents; Cyclotrons; Diagnostic Imaging; Endothelial Cells; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunohistochemistry; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Peptides; Positron-Emission Tomography; Protein Binding; Receptors, Vascular Endothelial Growth Factor; Time Factors; Vascular Endothelial Growth Factor A | 2013 |